Search research articles
Contact Us
Filters
Showing results (61-70 of 105) with videos related to
Page
of 11
Sort By:
Hepatology International
|
August 10, 2020
Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression
Chih-Lang Lin, Rong-Nan Chien, Yu-De Chu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 5, 2019
New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy
Ching-Chih Hu, Cheng-Hao Weng, Man-Chin Hua, et al.
In Vivo (Athens, Greece)
|
June 28, 2017
Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon Treatment
Puo-Hsien Le, Kung-Hao Liang, Ming-Ling Chang, et al.
Cancer Cell International
|
June 21, 2025
HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression
Yang-Hsiang Lin, Ming-Wei Lai, Yu-De Chu, et al.
International Journal of Molecular Sciences
|
October 27, 2022
The Mutation Hotspots at UGT1A Locus May Be Associated with Gilbert's Syndrome Affecting the Taiwanese Population
Paul Wei-Che Hsu, Po-Cheng Liao, Yu-Hsiang Kao, et al.
Journal of Clinical Gastroenterology
|
November 4, 2024
Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Cirrhosis
Tien-Shin Chou, Yuan Lin, Ming-Lung Tsai, et al.
Hepatology (Baltimore, Md.)
|
August 25, 2023
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis
Wen-Juei Jeng, Rong-Nan Chien, Yi-Cheng Chen, et al.
Clinical Therapeutics
|
April 26, 2022
Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in Taiwan
Chih-Lang Lin, Yi-Lan Lin, Kung-Hao Liang, et al.
The Pharmacogenomics Journal
|
October 16, 2019
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy
Chen-Chun Lin, Chao-Wei Hsu, Yi-Cheng Chen, et al.
Journal of Viral Hepatitis
|
February 11, 2020
Real-world experience of elbasvir/grazoprevir in Taiwan: This study was focused on liver and renal adverse effects
Yi-Chung Hsieh, Chih-Lang Lin, Chao-Hung Hung, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 105) with videos related to
Sort By:
Page
of 11
Hepatology International
|
August 10, 2020
Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression
Chih-Lang Lin, Rong-Nan Chien, Yu-De Chu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 5, 2019
New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy
Ching-Chih Hu, Cheng-Hao Weng, Man-Chin Hua, et al.
In Vivo (Athens, Greece)
|
June 28, 2017
Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon Treatment
Puo-Hsien Le, Kung-Hao Liang, Ming-Ling Chang, et al.
Cancer Cell International
|
June 21, 2025
HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression
Yang-Hsiang Lin, Ming-Wei Lai, Yu-De Chu, et al.
International Journal of Molecular Sciences
|
October 27, 2022
The Mutation Hotspots at UGT1A Locus May Be Associated with Gilbert's Syndrome Affecting the Taiwanese Population
Paul Wei-Che Hsu, Po-Cheng Liao, Yu-Hsiang Kao, et al.
Journal of Clinical Gastroenterology
|
November 4, 2024
Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Cirrhosis
Tien-Shin Chou, Yuan Lin, Ming-Lung Tsai, et al.
Hepatology (Baltimore, Md.)
|
August 25, 2023
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis
Wen-Juei Jeng, Rong-Nan Chien, Yi-Cheng Chen, et al.
Clinical Therapeutics
|
April 26, 2022
Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in Taiwan
Chih-Lang Lin, Yi-Lan Lin, Kung-Hao Liang, et al.
The Pharmacogenomics Journal
|
October 16, 2019
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy
Chen-Chun Lin, Chao-Wei Hsu, Yi-Cheng Chen, et al.
Journal of Viral Hepatitis
|
February 11, 2020
Real-world experience of elbasvir/grazoprevir in Taiwan: This study was focused on liver and renal adverse effects
Yi-Chung Hsieh, Chih-Lang Lin, Chao-Hung Hung, et al.
Page
of 11